Curettage-electrodesiccation treatment of basal cell carcinomas
- PMID: 848972
Curettage-electrodesiccation treatment of basal cell carcinomas
Abstract
Cure rates after treatment of basal cell carcinomas with curettage-electrodesiccation were compared among three groups: group A, 597 lesions treated in the Skin and Cancer Unit in 1958 to 1962; group B, 91 lesions treated in the Skin and Cancer Unit in 1970; and group C, 210 lesions treated in private practice in 1962 to 1973. The following were the five-year cumulative recurrence rates: group A, 18.8%; group B, 9.6%; and group C, 5.7%. In all three groups, there were high recurrence rates for tumors treated on the nose, paranasal areas, and forehead. Few complications occurred after curettage-electrodesiccation with the exception of hypertrophic scars. The cosmetic results following curettage-electrodesication improved with time. Curettage-electrodesiccation, when performed by experienced physicians, is a very useful modality for the treatment of basal cell carcinomas, with cure rates of over 90%, satisfactory cosmetic results, and few significant complications.
Similar articles
-
Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.J Am Acad Dermatol. 2007 Jan;56(1):91-5. doi: 10.1016/j.jaad.2006.07.007. J Am Acad Dermatol. 2007. PMID: 17190625 Clinical Trial.
-
Multivariate risk score for recurrence of cutaneous basal cell carcinomas.Arch Dermatol. 1983 May;119(5):373-7. Arch Dermatol. 1983. PMID: 6847215
-
Failure of curettage and electrodesiccation for removal of basal cell carcinoma.Arch Dermatol. 1984 Nov;120(11):1456-60. Arch Dermatol. 1984. PMID: 6497413
-
Treatment of skin malignancies.J Fam Pract. 2003 Jun;52(6):456-64. J Fam Pract. 2003. PMID: 12791228 Review.
-
Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up.J Dermatol Surg Oncol. 1989 Mar;15(3):315-28. doi: 10.1111/j.1524-4725.1989.tb03166.x. J Dermatol Surg Oncol. 1989. PMID: 2646336 Review.
Cited by
-
Nonsurgical Options for the Treatment of Basal Cell Carcinoma.Dermatol Pract Concept. 2019 Apr 30;9(2):75-81. doi: 10.5826/dpc.0902a01. eCollection 2019 Apr. Dermatol Pract Concept. 2019. PMID: 31106008 Free PMC article.
-
Modeling capsule tissue growth around disk-shaped implants: a numerical and in vivo study.J Math Biol. 2008 Nov;57(5):675-95. doi: 10.1007/s00285-008-0184-0. Epub 2008 May 17. J Math Biol. 2008. PMID: 18488226
-
Modern Chemosurgery--microscopically controlled excision.West J Med. 1980 Jan;132(1):7-12. West J Med. 1980. PMID: 7376652 Free PMC article.
-
Test characteristics of high-resolution ultrasound in the preoperative assessment of margins of basal cell and squamous cell carcinoma in patients undergoing Mohs micrographic surgery.Dermatol Surg. 2009 Jan;35(1):9-15; discussion 15-6. doi: 10.1111/j.1524-4725.2008.34376.x. Epub 2008 Nov 19. Dermatol Surg. 2009. PMID: 19018815 Free PMC article.
-
Focus on Basal cell carcinoma.J Skin Cancer. 2011;2011:328615. doi: 10.1155/2011/328615. Epub 2010 Oct 24. J Skin Cancer. 2011. PMID: 21152128 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources